Consentement d'utilisation des Cookies

J'accepte Notre site sauvegarde des traceurs textes (cookies) sur votre appareil afin de vous garantir de meilleurs contenus et à des fins de collectes statistiques.Vous pouvez désactiver l'usage des cookies en changeant les paramètres de votre navigateur. En poursuivant votre navigation sur notre site sans changer vos paramètres de navigateur vous nous accordez la permission de conserver des informations sur votre appareil.

54965-24-1 - Tamoxifen citrate - cis-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene citrate - J60955 - Alfa Aesar

J60955 Tamoxifen citrate

Numéro CAS
54965-24-1
Synonymes
cis-1-(4-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene citrate

Dimensions Prix ($) Quantité Disponibilité
1g 192,61
5g 468,00
Ajouter au panier Ajouter au devis en vrac Afficher l'article

Tamoxifen citrate

MDL
MFCD00058321
EINECS
259-415-2

Propriétés chimiques

Formule
C26H29NO.C6H8O7
Poids formulaire
563.65
Forme
White to off-white powder
Sensibilité
Light Sensitive & Hygroscopic
Solubilité
Soluble in methanol (50 mg/ml with heat) or ethanol (10 mg/ml with sonication); very slightly soluble in water (0.3 mg/L @ 20°C; the pH is approximately 3.0-3.5), 0.02 N HCl (0.2 mg/ml @ 37°C)4, acetone ,chloroform,and DMSO(100mM)

Applications

Tamoxifen citrate is used as an antiestrogen with potent anti-cancer and PKC inhibitory activities. Tamoxifen Citrate functions as an estrogen receptor antagonist in breast tissue. Tamoxifen Citrate is an agonist towards this receptor in tissues of the endometrium. Tamoxifen Citrate inhibits DNA synthesis and transcription by recruiting co-repressors, which stop estrogen from interacting with genes. When combined with PAX2, Tamoxifen Citrate can inhibit the proliferation of ERBB2. It is also a high affinity activator of the GPR30 receptor. Tamoxifen Citrate is an activator of Estrogen Receptor.

Notes

Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Recommended storage temperature: 2 - 8°C. Keep away from strong oxidizing agents.

Références bibliographiques

Wakeling et al. Non-steroidal anti-estrogens - receptor binding and biological response in rat uterus, rat mammary carcinoma and human breast cancer cells. J.Steroid.Biochem. 1984, 20,(1), 111-20.

Paul et al. Both the immunosuppressant SR31747 and the antioestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Δ8-Δ7 sterol isomerase. J.Pharmacol.Exp.Ther. 1998, 285,(3), 1296-302.

Mentions de danger et de prudence du SGH

Mentions de danger (UE): H350-H360-H362-H302

May cause cancer. May damage fertility or the unborn child. May cause harm to breast-fed children. Harmful if swallowed.

Mentions de prudence: P263-P260-P201-P281-P264-P270-P301+P312-P308+P313-P405-P501a

Avoid contact during pregnancy/while nursing. Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Use personal protective equipment as required. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. IF exposed or concerned: Get medical advice/attention. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Autres références

Merck
14,9048
Code tarifaire harmonisé
2922.29
TSCA
No
RTECS
KH2387000

Recommandé

Consulté récemment

Produits chimiques

Sciences de la vie

Métaux et matériaux

Catalyseurs

Analytique et matériel de laboratoire